Effects of prostaglandins on the cytosolic free calcium concentration in vascular smooth muscle cells. 1986

K Fukuo, and S Morimoto, and E Koh, and S Yukawa, and H Tsuchiya, and S Imanaka, and H Yamamoto, and T Onishi, and Y Kumahara

The effects of prostaglandin (PG) F2 alpha and 9,11-epithio-11,12-methanothromboxane A2 (STA2), a stable analogue of thromboxane A2, on the cytosolic free calcium concentration ([Ca2+]i) in vascular smooth muscle cells were studied with a new fluorescent Ca2+ indicator fura 2. PGF2 alpha and STA2, which are strong vasoconstrictors, caused rapid phasic and subsequent tonic increases in [Ca2+]i. PGF2 alpha caused dose-dependent elevation of [Ca2+]i not only in control solution but also in the calcium-free solution. A first stimulation with PGF2 alpha caused dose-dependent decrease in the response of [Ca2+]i to a second stimulation with PGF2 alpha. Pretreatment with 13-Azaprostanoic acid, a receptor level antagonist of thromboxane A2 inhibited the increase of [Ca2+]i induced by STA2. These results suggest that PGF2 alpha induces calcium mobilization followed by smooth muscle contraction through its specific receptors.

UI MeSH Term Description Entries
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D011460 Prostaglandins F (9 alpha,11 alpha,13E,15S)-9,11,15-Trihydroxyprost-13-en-1-oic acid (PGF(1 alpha)); (5Z,9 alpha,11,alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid (PGF(2 alpha)); (5Z,9 alpha,11 alpha,13E,15S,17Z)-9,11,15-trihydroxyprosta-5,13,17-trien-1-oic acid (PGF(3 alpha)). A family of prostaglandins that includes three of the six naturally occurring prostaglandins. All naturally occurring PGF have an alpha configuration at the 9-carbon position. They stimulate uterine and bronchial smooth muscle and are often used as oxytocics. PGF
D011466 Prostanoic Acids 2-Octylcyclopentaneheptanoic acids. The family of saturated carbon-20 cyclic fatty acids that represent the parent compounds of the prostaglandins. Acids, Prostanoic
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D005260 Female Females
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001572 Benzofurans Compounds that contain a BENZENE ring fused to a furan ring. Coumarones,Diphenylbenzofuran

Related Publications

K Fukuo, and S Morimoto, and E Koh, and S Yukawa, and H Tsuchiya, and S Imanaka, and H Yamamoto, and T Onishi, and Y Kumahara
July 1993, Cardiovascular research,
K Fukuo, and S Morimoto, and E Koh, and S Yukawa, and H Tsuchiya, and S Imanaka, and H Yamamoto, and T Onishi, and Y Kumahara
January 1996, Clinical science (London, England : 1979),
K Fukuo, and S Morimoto, and E Koh, and S Yukawa, and H Tsuchiya, and S Imanaka, and H Yamamoto, and T Onishi, and Y Kumahara
January 2001, Methods in molecular medicine,
K Fukuo, and S Morimoto, and E Koh, and S Yukawa, and H Tsuchiya, and S Imanaka, and H Yamamoto, and T Onishi, and Y Kumahara
July 2006, Asian journal of andrology,
K Fukuo, and S Morimoto, and E Koh, and S Yukawa, and H Tsuchiya, and S Imanaka, and H Yamamoto, and T Onishi, and Y Kumahara
August 2007, Andrologia,
K Fukuo, and S Morimoto, and E Koh, and S Yukawa, and H Tsuchiya, and S Imanaka, and H Yamamoto, and T Onishi, and Y Kumahara
January 1985, Hypertension (Dallas, Tex. : 1979),
K Fukuo, and S Morimoto, and E Koh, and S Yukawa, and H Tsuchiya, and S Imanaka, and H Yamamoto, and T Onishi, and Y Kumahara
August 2003, Zhonghua nan ke xue = National journal of andrology,
K Fukuo, and S Morimoto, and E Koh, and S Yukawa, and H Tsuchiya, and S Imanaka, and H Yamamoto, and T Onishi, and Y Kumahara
March 1987, Biochemical and biophysical research communications,
K Fukuo, and S Morimoto, and E Koh, and S Yukawa, and H Tsuchiya, and S Imanaka, and H Yamamoto, and T Onishi, and Y Kumahara
August 1985, Science (New York, N.Y.),
K Fukuo, and S Morimoto, and E Koh, and S Yukawa, and H Tsuchiya, and S Imanaka, and H Yamamoto, and T Onishi, and Y Kumahara
December 1995, Journal of hypertension,
Copied contents to your clipboard!